Microvascular photodynamic effects determined in vivo using optical Doppler tomography

Vascular responses were monitored to understand the role of the microvasculature in tumor destruction as a result of photodynamic therapy (PDT). Rats received an intravenous dose of 2 mg/kg Benzoporphyrin Derivative (BPD), at 20 min, 4 h, or 7 h before laser irradiation. With Photofrin (10 mg/kg), drug-light intervals were 20 min or 8 h. Jejunal blood vessels were exposed to 12 J/cm/sup 2/ at 690 nm (with BPD) or at 630 nm (with Photofrin). Optical Doppler tomography (ODT) was used to evaluate PDT-induced changes in vessel diameter and blood flow. At the shortest drug-light time interval (20 min), BPD-mediated PDT caused transient constriction of arteries, accompanied by decreased blood flow, followed by vasodilation until baseline was reached or overshoot occurred. Veins became occluded with no restoration of the vessel lumen. At longer drug-light intervals, vasoconstriction diminished and venodilation was observed. With Photofrin, vasoconstriction and venodilation increased with the drug-light interval. Application of a higher light dose (48 J/cm/sup 2/) resulted in irreversible hemostasis. ODT can be used to study changes in lumen diameter and blood flow, which are important diagnostic parameters of PDT.

[1]  T Lindmo,et al.  Accuracy and noise in optical Doppler tomography studied by Monte Carlo simulation. , 1998, Physics in medicine and biology.

[2]  D. Kessel,et al.  Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. , 1998, Journal of Investigative Dermatology.

[3]  M Bamberg,et al.  Photodynamic Synovectomy Using Benzoporphyrin Derivative in an Antigen‐induced Arthritis Model for Rheumatoid Arthritis , 1998, Photochemistry and photobiology.

[4]  Zhongping Chen,et al.  Optical Doppler Tomography: Imaging in vivo Blood Flow Dynamics Following Pharmacological Intervention and Photodynamic Therapy , 1998, Photochemistry and photobiology.

[5]  T. Wieman,et al.  The Effects of Thrombocytopenia on Vessel Stasis and Macromolecular Leakage after Photodynamic Therapy Using Photofrin , 1997, Photochemistry and photobiology.

[6]  A. Goetz,et al.  Targeting of the tumor microcirculation by photodynamic therapy with a synthetic porphycene. , 1997, Journal of photochemistry and photobiology. B, Biology.

[7]  J. Izatt,et al.  In vivo bidirectional color Doppler flow imaging of picoliter blood volumes using optical coherence tomography. , 1997, Optics letters.

[8]  M. V. van Gemert,et al.  Noninvasive imaging of in vivo blood flow velocity using optical Doppler tomography. , 1997, Optics letters.

[9]  Anil K. Jain,et al.  Delivery of Benzoporphyrin Derivative, a Photosensitizer, into Atherosclerotic Plaque of Watanabe Heritable Hyperlipidemic Rabbits and Balloon‐Injured New Zealand Rabbits , 1997, Photochemistry and photobiology.

[10]  S. Moncada.  Nitric Oxide in the Vasculature: Physiology and Pathophysiology , 1997, Annals of the New York Academy of Sciences.

[11]  K. Svanberg,et al.  Superficial blood flow following photodynamic therapy of malignant non–melanoma skin tumours measured by laser Doppler perfusion imaging , 1997, The British journal of dermatology.

[12]  A. Obwegeser,et al.  Photodynamic therapy in neurosurgery: a review. , 1996, Journal of photochemistry and photobiology. B, Biology.

[13]  R. Furchgott.  The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. , 1996, JAMA.

[14]  N. J. Brown,et al.  The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo. , 1995, British Journal of Cancer.

[15]  B. Henderson,et al.  PHOTOSENSITIZATION OF MURINE TUMOR, VASCULATURE and SKIN BY 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRIN , 1995, Photochemistry and photobiology.

[16]  S. Kimel,et al.  In vivo damage to chorioallantoic membrane blood vessels by porphycene-induced photodynamic therapy. , 1995, Journal of photochemistry and photobiology. B, Biology.

[17]  H. Schaff,et al.  Coronary artery endothelial function after myocardial ischemia and reperfusion. , 1995, The Annals of thoracic surgery.

[18]  J. Nelson,et al.  Characterization of fluid flow velocity by optical Doppler tomography. , 1995, Optics letters.

[19]  E. Newman,et al.  TIME‐DEPENDENT PHOTODYNAMIC DAMAGE TO BLOOD VESSELS: CORRELATION WITH SERUM PHOTOSENSITIZER LEVELS , 1995, Photochemistry and photobiology.

[20]  R. Keck,et al.  Photodynamic therapy of tumors: effects of hematoporphyrin derivative on normal rat intestine. , 1994, Cellular and molecular biology.

[21]  P. H. Moore,et al.  Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response. , 1994, Cancer research.

[22]  J. Moore.  Photodynamic Therapy: Basic Principles and Clinical Applications , 1993, British Journal of Cancer.

[23]  W. Star,et al.  Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas. , 1993, Cancer research.

[24]  P B Cerrito,et al.  The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer research.

[25]  J Moan,et al.  PHOTOCHEMOTHERAPY OF CANCER: EXPERIMENTAL RESEARCH , 1992, Photochemistry and photobiology.

[26]  T J Flotte,et al.  Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia. , 1992, Circulation.

[27]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[28]  H Anholt,et al.  Sensitizer for photodynamic therapy of cancer: A comparison of the tissue distribution of photofrin ii and aluminum phthalocyanine tetrasulfonate in nude mice bearing a human malignant tumor , 1991, International journal of cancer.

[29]  B. Tromberg,et al.  In vivo TUMOR OXYGEN TENSION MEASUREMENTS FOR THE EVALUATION OF THE EFFICIENCY OF PHOTODYNAMIC THERAPY , 1990, Photochemistry and photobiology.

[30]  M T Tseng,et al.  A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation. , 1989, Radiation research.

[31]  David H. Laidlaw,et al.  The application visualization system: a computational environment for scientific visualization , 1989, IEEE Computer Graphics and Applications.

[32]  M W Berns,et al.  Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. , 1988, Journal of the National Cancer Institute.

[33]  B. Henderson,et al.  DRUG and LIGHT DOSE DEPENDENCE OF PHOTODYNAMIC THERAPY: A STUDY OF TUMOR and NORMAL TISSUE RESPONSE , 1987, Photochemistry and photobiology.

[34]  W. Star,et al.  Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. , 1986, Cancer research.

[35]  R. Keck,et al.  Jejunal blood flow after exposure to light in rats injected with hematoporphyrin derivative. , 1985, Cancer research.

[36]  M. Berns,et al.  In vitro and in vivo comparison of argon‐pumped and diode lasers for photodynamic therapy using second‐generation photosensitizers , 1998, Lasers in surgery and medicine.

[37]  Zhongping Chen,et al.  Optical Doppler tomographic imaging of fluid flow velocity in highly scattering media. , 1997, Optics letters.

[38]  T. Dougherty.  Photodynamic therapy. , 1993, Photochemistry and photobiology.